Accelerating Precision Medicine

POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer
What are radioligands?

Improving cancer outcomes with Radioligand Therapies

Founded in late 2019, POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. Radioligands offer improved efficacy and superior safety profiles versus platform chemotherapy agents and can provide patients and their families the very best possible outcomes.
Learn More about Radioligand Therapies

The science of Radioligand Therapy

Although it may seem futuristic, radioligand therapy is a safe and proven treatment method for a variety of cancers.
Learn More about Radioligand Therapies

Our Treatment Pipeline

We are dedicated to expanding access to radioligand therapies, making them applicable to more cancers, accessible to more people, and improving the lives of patients and their families. Here are the compounds we are currently developing:

PNT2001

Currently at the pre-clinical stage, PNT2001 is a radioligand based therapy for treating prostate cancer.
Learn more about our Prostate Cancer Treatment >

PNT2001

Currently at the pre-clinical stage, PNT2001 is a radioligand based therapy for treating prostate cancer.
Learn more about our Prostate Cancer Treatment >

PNT2001

Currently at the pre-clinical stage, PNT2001 is a radioligand based therapy for treating prostate cancer.
Learn more about our Prostate Cancer Treatment >

PNT2001

Currently at the pre-clinical stage, PNT2001 is a radioligand based therapy for treating prostate cancer.
Learn more about our Prostate Cancer Treatment >

Help improve the lives of patients and their families

We are hiring for clinical, manufacturing and business roles

News

POINT Biopharma to Launch First US Manufacturing Facility in Indiana

Service and providing potential clients and customers with testimonials is one of the best ways to market.

POINT Biopharma Announces Phase 3 Prostate Cancer Trial

Service and providing potential clients and customers with testimonials is one of the best ways to market.

POINT Biopharma Announces Global Prostate Oncology Therapeutic Board of Advisors

Service and providing potential clients and customers with testimonials is one of the best ways to market.

Our newsletter

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By signing up you agree to our Terms & Conditions